Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2009
10/01/2009US20090246794 Methods and Kit for Detecting Breast Cancer
10/01/2009US20090246793 Cudr as biomarker for cancer progression and therapeutic response
10/01/2009US20090246781 Method for early determination of recurrence after therapy for prostate cancer
10/01/2009US20090246779 Increasing genomic instability during premalignant neoplastic progression revealed through high resolution array-cgh
10/01/2009US20090246778 Identification of fat and lean phenotypes in chickens using molecular markers
10/01/2009US20090246773 Diagnostic compositions and treatment methods for conditions involving trophoblast cell death, differentiation, invasion and/or cell fusion and turnover
10/01/2009US20090246769 Molecular diagnosis of ovarian cancers
10/01/2009US20090246768 Predicting and Diagnosing Patients With Autoimmune Disease
10/01/2009US20090246765 Method and device for detecting target substance using probe carrier
10/01/2009US20090246757 Method, Program, and System for Normalizing Gene Expression Amounts
10/01/2009US20090246752 Apparatus and method for detecting microscopic living organisms using bacteriophage
10/01/2009US20090246340 Synthetic Ligands Able to Bind Ochratoxin A and Uses Thereof
10/01/2009US20090246316 Esterase gene and use thereof
10/01/2009US20090246289 System and method for diagnosing and managing those at risk for cardiovascular disease
10/01/2009US20090246272 Mda-7 proteins and methods of use thereof
10/01/2009US20090246228 Moraxella catarrhalis Proteins
10/01/2009US20090246206 Bispecific binding agents for modulating biological activity
10/01/2009US20090246205 Inhibition of macrophage-stimulating protein receptor (ron)
10/01/2009US20090246200 Anthrax carbohydrates, synthesis and uses thereof
10/01/2009US20090246191 Preparation of Purified Covalently Cross-linked Abeta Oligomers and Uses Thereof
10/01/2009US20090246183 eNOS mutations useful for gene therapy and therapeutic screening
10/01/2009US20090246137 Pyridyl derivatives as cftr modulators
10/01/2009US20090246132 Epitope bound by MAbs A, B, C or D, where MAbs A, B, C and D have given variable domains; chimeric or humanized for side effect reduction; polymerase chain reaction
10/01/2009US20090246131 Production and Use of Novel Peptide-Based Agents for Use with Bi-Specific Antibodies
10/01/2009US20090245610 Method and Apparatus for Detecting Irregularities in Tissue Microarrays
10/01/2009US20090245588 Method And Apparatus For Determining Particle Parameter And Processor Performance In A Coal And Mineral Processing System
10/01/2009US20090245324 Compound sensor
10/01/2009US20090244517 Method for evaluating purity and concentration of oils and fatty acid compositions
10/01/2009US20090243635 Analysis of thin liquid films
10/01/2009US20090242756 Intensified neutral loss tags and use thereof in mass spectrometry
10/01/2009US20090242430 Electronic Methods for the Detection of Analytes
10/01/2009US20090242428 Method for determining the concentration of an analyte in a liquid sample using small volume samples and fast test times
10/01/2009US20090242399 Analyte sensor
10/01/2009US20090241696 On-line production process of sand presenting a controlled methylene blue value
10/01/2009US20090241647 Tear Film Osmometry
10/01/2009US20090241645 System and method for determining transmission oil type
10/01/2009US20090241639 Method for the Detection of Gaseous Impurities in Materials
10/01/2009US20090241637 Device for recording measurement data
10/01/2009DE202009009839U1 Führungssystem aus Kunststoff für Bandsägen Management system of plastic for band saws
10/01/2009DE102008016064A1 Verfahren zur Diagnose und Behandlung von chronisch psychiatrischen Erkrankungen sowie Marker und Targets für solche Verfahren A process for diagnosis and treatment of psychiatric disorders and chronic markers and targets for such methods
10/01/2009DE102007055865B3 Modifizierte Multi-Well-Platte für biochemische Analysen und Zellkulturexperimente Modified multi-well plate for biochemical analyzes and cell culture experiments
10/01/2009DE102005063290B4 Verfahren zum Betätigen einer chemischen Reaktionspatrone A method of operating a chemical reaction cartridge
10/01/2009DE102004019641B4 FET-basierter Gassensor FET-based gas sensor
10/01/2009CA2719800A1 Paper-based microfluidic systems
10/01/2009CA2719772A1 A system and method for providing a compositional measurement of a mixture having entrained gas
10/01/2009CA2719579A1 Methods of chemotype evolution
10/01/2009CA2719553A1 Novel sequences of brachyspira, immunogenic compositions, methods for preparation and use thereof
10/01/2009CA2719398A1 System for ultrasonically detecting defects in a pipe wall
10/01/2009CA2719339A1 Continuous measurement of amine loading in gas processing plants using raman spectroscopy
10/01/2009CA2719322A1 Cotton thread as a low-cost multi-assay diagnostic platform
10/01/2009CA2719320A1 Three-dimensional microfluidic devices
10/01/2009CA2719312A1 Detection of head and neck cancer using hypermethylated gene detection
10/01/2009CA2719255A1 Biosensor with improved analyte specificity
10/01/2009CA2719247A1 Ikki inhibitor therapies and screening methods, and related ikki diagnostics
10/01/2009CA2719062A1 Use of cathepsin c
10/01/2009CA2719041A1 Compositions, methods, and kits
10/01/2009CA2718321A1 Human anti-mesothelin monoclonal antibodies
10/01/2009CA2718146A1 Novel n- and c-terminal substituted antagonistic analogs of gh-rh
10/01/2009CA2715816A1 Hematopoietic cells expressing the protein krtcap3 and ligands for the protein krtcap3
10/01/2009CA2712535A1 An anti-cancer cytotoxic monoclonal antibody
09/2009
09/30/2009EP2105742A1 Use of cathepsin C
09/30/2009EP2105741A2 Use of a virus expressing a binding moiety to measure analytes in a sample
09/30/2009EP2105740A1 Biomarkers for monitoring or predicting the treatment of cancer
09/30/2009EP2105739A1 Dry analytical element capable of reducing influence of hemolysis for body fluid component measurement
09/30/2009EP2105737A1 System for ultrasonically detecting defects in a pipe wall
09/30/2009EP2105511A1 Medicament compositions and substances for treatment and identifying adenocarcinoma of the lung
09/30/2009EP2105509A1 Multilayer dry analytical element for pancreatic lipase measurment
09/30/2009EP2105508A1 Dry analytical element for pancreatic lipase measurement
09/30/2009EP2105504A2 Genes and proteins, and their use
09/30/2009EP2105502A1 Compositions and methods for the therapy and diagnosis of lung cancer
09/30/2009EP2105485A1 Dual component compound with mixture control agents
09/30/2009EP2105447A1 Avian-derived antibody capable of binding specifically to human hmgb1, immunological determination method for human hmgb1, and immunological determination reagent for human hmgb1
09/30/2009EP2105446A2 Cytokine receptor zalpha11
09/30/2009EP2104898A2 Signature simulator
09/30/2009EP2104855A1 Method and device for determining the quality of a hygroscopic material and for classifying and sorting it
09/30/2009EP2104854A1 Device for the qualification of cooking oils, and methods
09/30/2009EP2104742A2 A high sensitivity assay for molecular typing of biological sample, probes and a kit thereof
09/30/2009EP2104741A1 Bioluminescent assays utilising secreted luciferases
09/30/2009EP2104732A1 Cancerous disease modifying antibodies
09/30/2009EP2104512A2 Streptococcus proteins, and their use in vaccination
09/30/2009EP2104509A2 Compositions and methods for treating pathologic angiogenesis and vascular permeability
09/30/2009EP2081025A9 Method for determining the amino acid sequence of peptides
09/30/2009EP2054729B1 Process and apparatus for ion channel characterization
09/30/2009EP1739186B1 Method of screening compound capable of accelerating or inhibiting apoptosis, apoptosis accelerator and apoptosis inhibitor
09/30/2009EP1693378B1 Protein nmb1125 and use thereof in pharmaceutical formulations
09/30/2009EP1692503B1 A novel assay for screening antipsychotic drugs
09/30/2009EP1534075B1 Method for identifying salt-sensitive persons
09/30/2009EP1442305B1 Sensitivity controls for blood serology prepared from modified cells
09/30/2009EP1390380B1 Methods and primers for evaluating hiv-1 mutations
09/30/2009EP1389305B1 Peptide fragmentation
09/30/2009EP1342085B1 Non-apoptotic forms of cell death and methods of modulation
09/30/2009EP1328297B1 The function of a haptoglobin-haemoglobin receptor and the uses thereof
09/30/2009EP1297333B1 Ingestibles possessing intrinsic color change
09/30/2009EP1287153B1 Methods and compositions for efficient gene transfer using transcomplementary vectors
09/30/2009EP1282732B1 Fluorescent monomers and tagged treatment polymers containing same for use in industrial water systems
09/30/2009EP1261932B1 Methods for identifying polymorphic genetic markers
09/30/2009EP1240325B1 Il-17 and il-17r homologous polypeptides and therapeutic uses thereof
09/30/2009EP1151272B1 Simultaneous determination of equilibrium and kinetic properties
09/30/2009EP1141297B1 Interleukin-17 related mammalian cytokines. polynucleotides encoding them . uses
09/30/2009EP1105517B2 Rapid quantitative analysis of proteins or protein function in complex mixtures
1 ... 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 ... 3937